Clinical Trial: A Trial to Assess Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of SFL-0821 in Adults With FSHD

U.S., Sept. 2 -- ClinicalTrials.gov registry received information related to the study (NCT07798609) titled 'A Trial to Assess Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of SFL-0821 in Adults With FSHD' on Aug. 17.

Brief Summary: The purpose of this study is to evaluate the safety, tolerability, and preliminary efficacy of SFL-0821 in adult patients with Facioscapulohumeral Muscular Dystrophy (FSHD)

Study Start Date: Sept., 2026

Study Type: INTERVENTIONAL

Condition: Facioscapulohumeral Muscular Dystrophy (FSHD)

Intervention: DRUG: SFL-0821 for injection

single or multiple doses of SFL-0821 by intravenous (IV) infusion

DRUG: Placebo

calculated volume to match active treatment by IV infusion ...